|

- 积分
- 1
- 威望
- 1
- 包包
- 292
|
When Nature broke the news in December 2011 that Novartis
J" `' M1 l/ O- V: Q3 wwas to close its brain research facility in Basel, Switzerland,
' \3 \# I9 i: |the story noted that this move closely followed similar cuts
9 E5 \& f& V, M4 A( [/ O$ \by rival pharmaceutical firms. As a report from the European College
& n2 Q/ y, |$ b; J3 X ]of Neuropsychopharmacology
4 g- E% h% o( v) W. nhad warned a few months earlier, the
. v7 T0 A, j' T' |) s. n! h2 t" m+ Rabandonment of research into new psychiatric drugs by AstraZeneca,
# s- j' x( d( f' q9 `6 h# D# AGlaxoSmithKline
6 a; T/ M8 Z) u! K% {8 U1 xand others meant that “withdrawal of research
7 L! C2 W' D# o. V: x {: uresources is a withdrawal of hope for patients and their families”.% N2 E2 z; a x, R
' `- g) D, e6 K+ G3 K U3 c" E' g& R
回复有免费下载链接: J- d& P4 L* B. N! P" h
, e7 @2 j% L/ {5 o3 Z |
-
总评分: 包包 + 20
查看全部评分
|